InvestorsHub Logo
Followers 11
Posts 1565
Boards Moderated 0
Alias Born 09/19/2006

Re: None

Wednesday, 03/15/2017 7:36:04 PM

Wednesday, March 15, 2017 7:36:04 PM

Post# of 6401
GP, BP-1002 will not matter as the company will not pursue the drug anytime soon by themselves. Same with CML. The one positive is they have finally realized they need a laser focus on AML.

Brettj, Remember the company would not exist without PN. That said, as I have stated repeatedly one person holding the COB, CEO and CFO positions lacks the controls most institutional investors require. I admit that early on I gave PN the benefit of the doubt because he was the founder but now that he has become a flounderer something needs to be done. If we get delisted or pulled from the Russell, I believe it will be hard to recover.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News